1.
El-ASSAL MI, SAMUEL D. OPTIMIZATION OF RIVASTIGMINE CHITOSAN NANOPARTICLES FOR NEURODEGENERATIVE ALZHEIMER; IN VITRO AND EX VIVO CHARACTERIZATIONS. Int J Pharm Pharm Sci [Internet]. 2022 Jan. 1 [cited 2023 Feb. 1];14(1):17-2. Available from: https://innovareacademics.in/journals/index.php/ijpps/article/view/43145